Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population

Human Psychopharmacology

Volumn 25, Issue 6, 2010, Pages 481-486

  Kishi, Taro ^a   Fukuo, Yasuhisa ^a   Yoshimura, Reiji ^b   Okochi, Tomo ^a   Kitajima, Tsuyoshi ^a   Naitoh, Hiroshi ^a   Umene Nakano, Wakako ^b   Nakamura, Jun ^b   Ozaki, Norio ^c   Iwata, Nakao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Major depressive disorder (MDD); Pharmacogenetic study; Selective serotonin reuptake inhibitor (SSRI) response; Serotonin 6 receptor gene (HTR6); Tagging SNP

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLUVOXAMINE; PAROXETINE; SEROTONIN 6 RECEPTOR; SERTRALINE;

ADULT; ARTICLE; CASE CONTROL STUDY; DRUG EFFICACY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHARMACOGENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; JAPAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 77956573720     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1142     Document Type: Article

References (41)

1. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2): 263-265.
2. Bymaster FP, Falcone JF, Bauzon D, et al. 2001. Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine. Eur J Pharmacol 430(2-3): 341-349.
3. Chalmers DT, Watson SJ. 1991. Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain-a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res 561(1): 51-60.
4. DeBattista C, Hawkins J. 2009. Utility of atypical antipsychotics in the treatment of resistant unipolar depression. CNS Drugs 23(5): 369-377.
5. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2): 115-121.
6. Fone KC. 2008. An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function. Neuropharmacology 55(6): 1015-1022.
7. Fukuo Y, Kishi T, Yoshimura R, et al. 2010. Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis. Neurosci Res 67(3): 250-255.
8. Garriock HA, Kraft JB, Shyn SI, et al. 2010. A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 67(2): 133-138.
9. Harmer CJ. 2008. Serotonin and emotional processing: does it help explain antidepressant drug action? Neuropharmacology 55(6): 1023-1028.
10. Hirst WD, Minton JA, Bromidge SM, et al. 2000. Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue. Br J Pharmacol 130(7): 1597-1605.
11. Kato M, Serretti A. 2008. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry.
12. Kato T. 2007. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 61(1): 3-19.
13. King MV, Marsden CA, Fone KC. 2008. A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 29(9): 482-492.
14. Kishi T, Ikeda M, Kitajima T, et al. 2008a. No association between prostate apoptosis response 4 gene (PAWR) in schizophrenia and mood disorders in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 147B(4): 531-534.
15. Kishi T, Kitajima T, Ikeda M, et al. 2009a. Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. Eur Arch Psychiatry Clin Neurosci 259(5): 293-297.
16. Kishi T, Kitajima T, Ikeda M, et al. 2009b. CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients. Neuromolecular Med 11(2): 53-57.
17. Kishi T, Kitajima T, Ikeda M, et al. 2008b. Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population. Neurosci Res 62(4): 211-215.
18. Kishi T, Kitajima T, Ikeda M, et al. 2009c. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population. Neuropsychobiology 59(4): 234-238.
19. Kishi T, Kitajima T, Tsunoka T, et al. 2009d. Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population. Neurosci Res 64(2): 231-234.
20. Kishi T, Kitajima T, Tsunoka T, et al. 2009e. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population. Neuromolecular Med 11(2): 114-122.
21. Kishi T, Tsunoka T, Ikeda M, et al. 2009f. Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. J Hum Genet 54(11): 629-633.
22. Kishi T, Tsunoka T, Ikeda M, et al. 2010a. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology 58(2): 452-456.
23. Kishi T, Yoshimura R, Kitajima T, et al. 2010b. SIRT1 gene is associated with major depressive disorder in the Japanese population. J Affect Disord.
24. Kishi T, Yoshimura R, Kitajima T, et al. 2009g. HTR2A is Associated with SSRI Response in Major Depressive Disorder in a Japanese Cohort. Neuromolecular Med.
25. Kishi T, Yoshimura R, Okochi T, et al. 2010c. Association analysis of SIGMAR1 with major depressive disorder and SSRI response. Neuropharmacology 58(7): 1168-1173.
26. Kohen R, Metcalf MA, Khan N, et al. 1996. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 66(1): 47-56.
27. Kong A, Steinthorsdottir V, Masson G, et al. 2009. Parental origin of sequence variants associated with complex diseases. Nature 462(7275): 868-874.
28. Le Francois B, Czesak M, Steubl D, Albert PR. 2008. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 55(6): 977-985.
29. Lee SH, Lee KJ, Lee HJ, Ham BJ, Ryu SH, Lee MS. 2005. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder. Psychiatry Clin Neurosci 59(2): 140-145.
30. Levinson DF. 2006. The genetics of depression: a review. Biol Psychiatry 60(2): 84-92.
31. Liu HC, Hong CJ, Liu CY, et al. 2001. Association analysis of the 5-HT6 receptor polymorphism C267T with depression in patients with Alzheimer's disease. Psychiatry Clin Neurosci 55(4): 427-429.
32. Malhotra AK. 2010. The pharmacogenetics of depression: enter the GWAS. Am J Psychiatry 167(5): 493-495.
33. Manolio TA, Collins FS, Cox NJ, et al. 2009. Finding the missing heritability of complex diseases. Nature 461(7265): 747-753.
34. Papakostas GI. 2009. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry 70 (Suppl 6): 16-25.
35. Peveler R, Kendrick T. 2005. Selective serotonin reuptake inhibitors: THREAD trial may show way forward. Bmj 330(7488): 420-421.
36. Purcell S, Cherny SS, Sham PC. 2003. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1): 149-150.
37. Purohit A, Herrick-Davis K, Teitler M. 2003. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor. Synapse 47(3): 218-224.
38. Shyn SI, Shi J, Kraft JB, et al. 2009. Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Mol Psychiatry.
39. Uher R, Perroud N, Ng MY, et al. 2010. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 167(5): 555-564.
40. Vogt IR, Shimron-Abarbanell D, Neidt H, et al. 2000. Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. Am J Med Genet 96(2): 217-221.
41. Wu WH, Huo SJ, Cheng CY, Hong CJ, Tsai SJ. 2001. Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders. Neuropsychobiology 44(4): 172-175.